Reduces thrombosis. Thrombosis is the process of enzyme solution and activation of a series of plasma clotting factors, which eventually produces coagulation enzymes, which in turn produce fibrin clots. The new small molecule anticoagulant drug is to target certain coagulation factors or coagulation enzymes in the clotting process, inhibit or destroy its activity, thus destroying a certain part of the clotting process to inhibit blood clotting and thrombosis. Currently used clotting enzyme inhibitors are indirect clotting enzyme inhibitors and direct clotting enzyme inhibitors. The aforeid heparin-based drugs and coumarin drugs are the most common indirect clotting inhibitors in the clinic today.
正在翻译中..